Literature DB >> 16475875

Correlation of heavy and light chain mRNA copy numbers to antibody productivity in mouse myeloma production cell lines.

Haimanti Dorai1, Blanca Csirke, Bernie Scallon, Subinay Ganguly.   

Abstract

Manufacturing cell line development at Centocor involves transfection of antibody genes into host cell lines and isolating primary transfectomas that upon subcloning yield high expressing cell lines for the desired antibody. In an attempt to increase productivity of these cell lines, we set out to identify the rate-limiting step in the process of antibody expression and secretion. For this purpose, 30 antibody expressing cell lines with variable antibody expression levels were analyzed for heavy-chain and light-chain mRNA expression levels. Results suggested that the increase in antibody titer of the subclones (compared to their primary clones) was partly due to an increase in heavy-chain and light-chain mRNA levels; higher expressers were associated with approximately 1.0 x 10(7) and 1.5 x 10(7) copies of heavy-chain and light-chain per 10 nanogram of cDNA, respectively. Generally, the level of light-chain mRNA was higher compared to the level of heavy-chain mRNA in a majority of the cell lines, and the difference in their levels was not due to their differential stability. The data generated from all the cell lines tested in this study suggested that there was a correlation of light-chain and heavy-chain transcript levels to antibody productivity, with the coefficient of correlation being 0.59 for light chain and 0.81 for heavy chain. We conclude that transcription of heavy chain and to a lesser extent light chain could be one of the rate-limiting steps in the antibody expression pathway. Hence, methods that would increase these mRNA levels could be beneficial in the attempt to improve the antibody expression level of production cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475875     DOI: 10.1089/hyb.2006.25.1

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  6 in total

1.  In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.

Authors:  Elena S Klimtchuk; Tatiana B Prokaeva; Brian H Spencer; Olga Gursky; Lawreen H Connors
Journal:  Amyloid       Date:  2017-06-20       Impact factor: 7.141

2.  Dynamics of unfolded protein response in recombinant CHO cells.

Authors:  Kamal Prashad; Sarika Mehra
Journal:  Cytotechnology       Date:  2014-02-07       Impact factor: 2.058

3.  Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells.

Authors:  Y Prieto; L Rojas; L Hinojosa; I González; D Aguiar; K de la Luz; A Castillo; R Pérez
Journal:  Cytotechnology       Date:  2011-03-20       Impact factor: 2.058

4.  Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells.

Authors:  Fatemeh Nematpour; Fereidoun Mahboudi; Behrouz Vaziri; Vahid Khalaj; Samira Ahmadi; Maryam Ahmadi; Saedeh Ebadat; Fatemeh Davami
Journal:  BMC Biotechnol       Date:  2017-02-22       Impact factor: 2.563

5.  Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines.

Authors:  Thailin Lao-Gonzalez; Alexi Bueno-Soler; Arnelys Duran-Hernandez; Katya Sosa-Aguiar; Luis Eduardo Hinojosa-Puerta; Tays Hernandez-Garcia; Kathya Rashida de la Luz-Hernandez; Julio Palacios-Oliva; Tammy Boggiano-Ayo
Journal:  AMB Express       Date:  2021-01-03       Impact factor: 3.298

6.  Using molecular markers to characterize productivity in Chinese hamster ovary cell lines.

Authors:  Raihana Z Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.